Despite advancements in diagnosis, current biomarkers, such as alpha-fetoprotein (AFP), have limitations, including low sensitivity and specificity, especially when it comes to detecting early-stage HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.